The importance of a correct diagnosis in breast implant-associated anaplastic large cell lymphoma: Case report
1 Specialty Breast Group, Hospital Angeles del Pedregal.
2 Plastic Surgery, Hospital Angeles del Pedregal.
3 Facultad Mexicana de Medicina, Universidad La Salle.
Research Article
International Journal of Science and Technology Research Archive, 2023, 04(01), 312–317.
Article DOI: 10.53771/ijstra.2023.4.1.0048
Publication history:
Received on 09 February 2023; revised on 18 March 2023; accepted on 20 March 2023
Abstract:
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare neoplasm responsible for 0.04% to 0.5% of all cases of breast disease. It occurs in patients with a previous history of breast implants that generally progress without complications during the first years of post-operatory and is mainly associated with macro-textured implants. Due to its low incidence, it does not represent the first probable diagnosis in patients with a breast tumor. This article reports the case of a patient with BIA-ALCL initially treated as a Hodgkin's lymphoma. We emphasize the importance of a correct and complete diagnosis by immunohistochemistry before imaging in patients that develop a breast tumor associated with the prosthetic capsule after breast implant surgery and its adequate treatment, including surgery.
Keywords:
BIA-LCL; Immunohistochemistry; CD30; ALK
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0